Literature DB >> 7634552

Renal involvement in POEMS syndrome.

A Modesto-Segonds1, J P Rey, C Orfila, G Huchard, J M Suc.   

Abstract

We describe a patient with POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) who was found to have renal involvement with particular renal pathological findings. So far, 17 other cases, most of them from Japan, of POEMS syndrome with renal involvement, have been published. Clinical features are variable: acute renal failure with anasarca or moderate chronic renal insufficiency with mild proteinuria. This latter presentation often passes unnoticed. There is no severe hypertension, no microangiopathic hemolytic anemia. Renal biopsy shows prominent glomerular changes which are unusual and distinct from membranoproliferative glomerulonephritis (MPGN) and from glomerular thrombotic microangiopathy (TMA). Mesangial proliferation and thickening of the capillary wall with double contour on light microscopy suggest an MPGN. By immunofluorescent microscopy, no immunoglobulins or complement deposits were found. The occurrence of mesangiolytic lesions has led to the term of "mesangiolytic glomerulonephritis". The presence, on electron microscopy, of lucent subendothelial spaces could indicate TMA. But there are neither thrombi nor arteriolar changes. We are inclined to consider that the microangiopathic lesions are due to chronic injury of glomerular endothelial cells, exacerbated at outbreaks of the disease. Increased production of IL 6 could support the efficacy of corticosteroid therapy, particularly in acute clinical situations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7634552

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  7 in total

1.  Membranous nephropathy with thrombotic microangiopathy-like lesions successfully treated with tocilizumab in a patient with idiopathic multicentric Castleman disease.

Authors:  Takeshi Tosaki; Masahiro Okabe; Tomo Suzuki; Akihiro Shimizu; Kentaro Koike; Nobuo Tsuboi; Tetsuya Kawamura; Ryuji Ohashi; Shingo Yano; Takashi Yokoo
Journal:  CEN Case Rep       Date:  2021-01-02

2.  Serial renal biopsy findings in a case of POEMS syndrome with recurrent acute renal failure.

Authors:  Atsuko Y Higashi; Fumiaki Nogaki; Isoroku Kato; Takahiko Ono; Atsushi Fukatsu
Journal:  Clin Exp Nephrol       Date:  2011-10-08       Impact factor: 2.801

3.  A case of POEMS syndrome with severe kidney damage: lessons for the clinical nephrologist.

Authors:  Irina Rekhtina; Ekaterina Stolyarevich; Elena Zakharova; Victoria Khyshova; Larisa Mendeleeva
Journal:  J Nephrol       Date:  2022-06-23       Impact factor: 4.393

4.  A Patient with Abnormal Kidney Function and a Monoclonal Light Chain in the Urine.

Authors:  Nelson Leung; Samih H Nasr
Journal:  Clin J Am Soc Nephrol       Date:  2016-03-18       Impact factor: 8.237

5.  [POEMS syndrome. A rare variant of osteosclerotic multiple myeloma with polyneuropathy, organomegaly, endocrinopathy, M-gradient and skin lesions].

Authors:  M Cohnen; M Uppenkamp; P Meusers; G Brittinger
Journal:  Med Klin (Munich)       Date:  1998-11-15

6.  POEMS syndrome with renal plasmacytoma and classic polyarteritis nodosa: a case report.

Authors:  Pranaw Kumar Jha; Mahesha Vankalakunti; Ravishankar Bonu; Kishore Babu; H Sudarshan Ballal
Journal:  NDT Plus       Date:  2011-12

7.  The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

Authors:  Nelson Leung; Frank Bridoux; Vecihi Batuman; Aristeidis Chaidos; Paul Cockwell; Vivette D D'Agati; Angela Dispenzieri; Fernando C Fervenza; Jean-Paul Fermand; Simon Gibbs; Julian D Gillmore; Guillermo A Herrera; Arnaud Jaccard; Dragan Jevremovic; Efstathios Kastritis; Vishal Kukreti; Robert A Kyle; Helen J Lachmann; Christopher P Larsen; Heinz Ludwig; Glen S Markowitz; Giampaolo Merlini; Peter Mollee; Maria M Picken; Vincent S Rajkumar; Virginie Royal; Paul W Sanders; Sanjeev Sethi; Christopher P Venner; Peter M Voorhees; Ashutosh D Wechalekar; Brendan M Weiss; Samih H Nasr
Journal:  Nat Rev Nephrol       Date:  2019-01       Impact factor: 28.314

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.